What are the mechanisms linking novel antidiabetic treatments to cardiovascular benefit?

31 August 2020 (11:00 - 11:11)

Organised by:

Video

Sign in for access options

Slides

About the speaker

Professor Hiddo Heerspink

University Medical Centre Groningen, Groningen (Netherlands (The))

3 More presentations in this session

Presentation thumbnail

Best strategies for antithrombotic therapy and revascularization in patients with diabetes.

Professor B. Rocca (Casamassima, IT)

Presentation thumbnail

How should we balance the gluco-centric and the cardio-centric management of diabetes?

Professor A. Avogaro (Padova, IT)

Presentation thumbnail

How cardiac rehabilitation can help in the management of the cardiovascular patient with diabetes.

Professor D. Hansen (Hasselt, BE)

Access the full session

Session thumbnail

Balancing Treatment Needs for Diabetic Patients with Cardiovascular Disease

The Event

ESC Congress 2020

31 August 2020 11:00 CET

You may be interested in

Congress Session

Guidelines in Practice: 2023 ESC Guidelines for the Management of Cardiovascular Disease in Patients with Diabetes

27 August 2023

Congress Presentation

Effects of glucagon like peptide-1 receptor agonists, sodium-glucose cotransporter-2 inhibitors and their combination on vascular function and myocardial work index in patient with type-2 diabetes

28 August 2020

Congress Presentation

Meta-analysis of cardiovascular outcome trials assessing the cardiovascular efficacy and safety of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes mellitus

27 August 2021

Webinar

EAPC Webinar: Type 2 Diabetes and cardiovascular risk

12 March 2019

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources